Patents Examined by Mark Bockelman
  • Patent number: 11364380
    Abstract: In an embodiment, a nerve stimulation system includes a headset and an earpiece which includes two or more ear-contacting elements, for example an ear canal insert, and a concha insert. Ear-contacting elements may be mounted onto an earpiece housing have projecting mounting structures, which provide mechanical and electrical connection between ear-contacting elements and housing through various materials and configurations. In an embodiment, a nerve stimulation system includes a neural stimulation subsystem including neural stimulation device control circuitry for use in combination with a personal computing device to control a neural stimulation device.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: June 21, 2022
    Assignee: Elwha LLC
    Inventors: Eleanor V. Goodall, Roderick A. Hyde, Muriel Y. Ishikawa, Jordin T. Kare, Eric C. Leuthardt, Mark A. Malamud, Stephen L. Malaska, Nathan P. Myhrvold, Tim F. Ramsey, Brittany Scheid, Katherine E. Sharadin, Elizabeth A. Sweeney, Clarence T. Tegreene, Charles Whitmer, Lowell L. Wood, Jr., Victoria Y. H. Wood
  • Patent number: 11185686
    Abstract: The present invention relates to an intensive care device using anions, the device: intensively irradiating the affected area with anions such that the affected area is quickly healed, and allowing a patient's body to be in an electrostatically induced condition through grounding, and, in this condition, irradiating the affected area with anions such that an anionic charge is induced in the patient's body direction with linearity, thereby having excellent effects by minimizing anionic loss caused by cations in the air and maximizing the amount of irradiation directed toward the affected area; having a low-output light irradiation lens irradiated with blue wavelength light, which is a low-output ray, so as to exhibit a physically beneficial effect such as skin sterilization; and having a simple use and procedure compared with skin grafting or other medicines and medical supplies for skin regeneration.
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: November 30, 2021
    Assignee: FR MEDICAL LAB CO., LTD.
    Inventor: Ki-Sub Jung
  • Patent number: 11097111
    Abstract: Some implementations provide an implantable wirelessly powered device for implantation in a patient's body, the device including: two or more electrode arrays configured to apply at least one electrical pulse to an excitable tissue, each electrode array including at least one electrode; two or more connector contacts, each integrally wired to a particular electrode array, each configured to drive the at least one electrode of the particular electrode array integrally wired thereto with the at least one electrical pulse and to set a polarity for each of the at least one electrode of the particular electrode array integrally wired thereto; a first antenna configured to: receive, from a second antenna and through electrical radiative coupling, an input signal containing electrical energy as well as polarity assignment information, the second antenna located outside the patient's body; and one or more circuits electrically connected to the first antenna and the connector contacts, the circuits configured to: crea
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: August 24, 2021
    Assignee: Stimwave Technologies Incorporated
    Inventors: Laura Tyler Perryman, Chad David Andresen
  • Patent number: 11065458
    Abstract: An electronic pacemaker for implantation in a body of a living being including an electrode portion that is configured to be attached to a body portion; an electronics assembly connected with the electrode portion, configured to generate a voltage impulse emitted via the electrode portion to the body portion; a rechargeable accumulator to supply the electronics assembly with electrical energy; and a charging impulse generation portion electrically connected to the accumulator, configured to emit a charging impulse to the accumulator for the recharging of the accumulator. The charging impulse generation portion includes a magnetization portion with oriented magnetic domains which can be contactlessly influenced by an changing magnetic field so that, when a certain field strength is reached, a remagnetization wave, caused by the continuously reversing magnetic domains, occurs in the magnetization portion which runs across the magnetization portion and leads to the generation of the charging impulse.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: July 20, 2021
    Inventors: Walter Mehnert, Thomas Theil
  • Patent number: 11065461
    Abstract: An apparatus includes a power adapter having a housing and a circuit at least partially disposed in the housing. The housing is configured to be coupled to an implantable device for disposition in a body. The circuit is configured to be electrically connected to a power circuit of the implantable device when the housing is coupled to the implantable electrical conductor. When the housing is coupled to the implantable electrical conductor and implanted in a body, the circuit is configured to (1) receive, transcutaneously from a power supply, a first energy, (2) convert the first energy to a second energy, and (3) transfer, to the implantable device, the second energy such that the second energy powers the implantable device.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: July 20, 2021
    Assignee: Bioness Inc.
    Inventors: Keith McBride, Arkady Glukhovsky
  • Patent number: 11058889
    Abstract: Embodiments of the present disclosure provide systems, apparatuses and methods for regulation hormone production in mammals. Examples include but are not limited to by creating electro-magnetic wave emission pulse trains (photons) of individual color spectrums in sufficient intensity to drive hormone production in a mammal, using a characteristic frequency or pattern to minimize the required input power necessary to regulate hormone production, while also allowing for the monitoring of the power consumption and other variables of the system. By controlling the duty cycle, intensity, wavelength band and frequency of photon signals to a mammal, production of specific hormones can be regulated through the cycling between blue, green, yellow, near-red, far-red, infrared and ultra violet photon modulation.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: July 13, 2021
    Assignee: Xiant Technologies, Inc.
    Inventor: Jon Daren Suntych
  • Patent number: 11058356
    Abstract: A method for measuring a myocardial physiologic parameter according to an embodiment includes placing an at least partially convex portion of a spectral sensor against an intercostal space of a human over a heart of the human and measuring the physiologic parameter of a myocardium of the heart with the spectral sensor over time during an emergency medical event. The spectral sensor may be configured to determine and visually display a suggested position adjustment for directing the spectral radiation more directly toward the tissue of interest (e.g. the myocardium), and/or for placing the operative elements of the spectral sensor closer to the tissue of interest (e.g. the myocardium).
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: July 13, 2021
    Assignee: ZOLL Medical Corporation
    Inventors: Gary A. Freeman, Ulrich Herken, Christopher Kaufman, Annemarie Elizabeth Silver
  • Patent number: 11052247
    Abstract: A skin regeneration therapy combining precise bioelectric signals, light, and biologics for skin treatment and regeneration. Precise bioelectric signals give clear instructions to the stimulated cell DNA/RNA to produce specific regenerative proteins on demand. Bioelectric signals give clear instructions to cell membranes on what to let in and what to let out and serve as an equivalent or surrogate of environmental stimuli to cause a cell action in response.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: July 6, 2021
    Assignee: LEONHARDT VENTURES LLC
    Inventors: Howard J. Leonhardt, Jorge Genovese
  • Patent number: 11033328
    Abstract: Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for percutaneous intravascular delivery of pulsed electric fields to achieve such neuromodulation.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: June 15, 2021
    Assignee: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
    Inventors: Mark E. Deem, Hanson Gifford, III, Denise Zarins, Douglas Sutton, Erik Thai, Mark Gelfand, Howard R. Levin
  • Patent number: 11026623
    Abstract: We report a method of determining an occurrence of an epileptic convulsive seizure in a patient, comprising: receiving body data from a patient during a first time period, determining a work level relating to said first time period at least based partially upon said body data; determining whether said work level exceeds an extreme work level threshold; performing a responsive action, in response to a determination that said work level exceeds said extreme work level threshold. We also report a medical device system configured to implement the method. We also report a non-transitory computer readable program storage unit encoded with instructions that, when executed by a computer, perform the method.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: June 8, 2021
    Assignee: Flint Hills Scientific, L.L.C.
    Inventor: Ivan Osorio
  • Patent number: 11025843
    Abstract: The present invention relates to a device for the non-invasive determination of physiological parameters of a test person with a lighting unit (32), having a plurality of LED types whose emission maxima are at different wavelengths from the visible to the NIR wavelength range and include an emission maximum below 590 nm, a photo sensor for application to the skin, a data processing unit (11) for reading out the photo sensor and for controlling the illumination unit (32), so that the different types of LEDs individually in a predetermined activation sequence at successive activation start times tk (k=1, 2 . . . M) are activated for a respective predetermined activation period, and to repeat the activation sequence with a clock frequency as a result n=1, 2 . . .
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: June 1, 2021
    Assignee: Cinogy GmbH
    Inventors: Axel Kulcke, Amadeus Holmer
  • Patent number: 11000689
    Abstract: A leadless cardiac pacemaker is adapted for implantation into triangle of Koch or His bundle with a plurality of individual electrodes spread in the vicinity of implantation site. Individual electrodes are first evaluated for their suitability for sensing and pacing of atrial and ventricular chambers of the heart. Individual electrodes are then selected for delivery of cardiac pacing to multiple heart chambers from a single intra-cardiac location. Remaining non-selected individual electrodes may be abandoned. Also described is an adapter with multiple electrodes configured to dock with a conventional leadless or standard pacemaker to operate in the same way.
    Type: Grant
    Filed: December 16, 2018
    Date of Patent: May 11, 2021
    Assignee: Eagle Point Medical LLC
    Inventor: Leonid Makharinsky
  • Patent number: 10993633
    Abstract: A system and method for a multi-function remote ambulatory cardiac monitoring system. The system includes a housing and a microprocessor disposed within the housing. The microprocessor controls the remote ambulatory cardiac monitoring system. The system also includes an electrode for sensing ECG signals and the electrode being in communication with the microprocessor. An integrated cellular module also is included in the system, and the cellular module is connected to the microprocessor and disposed within the housing. The integrated cellular module transmits ECG signals to a remote center.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: May 4, 2021
    Assignee: ACS DIAGNOSTICS, INC.
    Inventor: Loren A. Manera
  • Patent number: 10993762
    Abstract: A surgical instrument includes an end effector and a housing mechanically coupled to the end effector. The end effector includes a first actuating device configured to perform a first surgical procedure and a second actuating device integrally associated with the first actuating device and configured to perform a second surgical procedure, the second surgical procedure being independently operable and different than the first surgical procedure. An outer portion of the first actuating device and an outer portion of the second actuating device form a portion of an outer housing of the end effector. The housing includes a first actuator, mechanically coupled to the first actuating device and configured to impart movement to the first actuating device and a second actuator, mechanically coupled to the second actuating device and configured to impart movement to the second actuating device.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: May 4, 2021
    Assignee: Covidien LP
    Inventor: David M. Garrison
  • Patent number: 10987192
    Abstract: A hyperdexterous surgical system is provided. The system on include one or more surgical arms coupleable in a fixture and configured to support one or more surgical tools. The system can include an electronic control system configured to communicate electronically with the one or more robotic surgical tools. The control system can electronically control the operation of the one or more surgical tools. The system can include one or more portable handheld controllers actuatable by a surgeon to communicate one or more control signals to the one or more surgical tools via the electronic control system to operate the one or more surgical tools. The one or more portable handheld controllers can provide said one or more control signals from a plurality of locations of an operating arena, allowing a surgeon to be mobile during a surgical procedure and to remotely operate the one or more surgical tools from different locations of the operating arena.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: April 27, 2021
    Assignee: SRI International
    Inventors: Pablo Eduardo Garcia Kilroy, Thomas D. Egan, Karen Shakespear Koenig
  • Patent number: 10981014
    Abstract: Dual sequential defibrillation (DSD) systems and methods include the use of a timing device. The timing device can assist a user with DSD administration by providing notifications spaced apart by the inter-shock timing. The user can use these notifications to trigger the administration of defibrillation in a sequential manner. The timing device can also be coupled to two defibrillation devices and can output a signal to each of the defibrillation devices to cause the defibrillation device to administer a defibrillation. The output of the signals by the timing device can be spaced apart by the inter-shock timing. Additionally, the signals can be QRS-like in nature to cause the defibrillation devices to administer a defibrillation when in a sync mode.
    Type: Grant
    Filed: April 3, 2018
    Date of Patent: April 20, 2021
    Assignee: The UAB Research Foundation
    Inventors: Tyson G. Taylor, Fred W. Chapman, Gregory Walcott
  • Patent number: 10980928
    Abstract: A blood pump system is implantable in a patient for ventricular support. A pumping chamber has an inlet for receiving blood from a ventricle of the patient. An impeller is received in the pumping chamber. A motor is coupled to the impeller for driving rotation of the impeller. A motor controller is provided for tracking systolic and diastolic phases of a cardiac cycle of the patient and supplying a variable voltage signal to the motor in a variable speed mode to produce a variable impeller speed linked to the cardiac cycle. The impeller speed comprises a ramping up to an elevated speed during the diastolic phase in order to reduce a load on the ventricle at the beginning of the systolic phase.
    Type: Grant
    Filed: September 20, 2019
    Date of Patent: April 20, 2021
    Assignee: TC1 LLC
    Inventors: Alexander Medvedev, Masamichi Yanai
  • Patent number: 10967180
    Abstract: A method for providing electrical current treatment by an apparatus having a first electrode, a second electrode, and a processor is provided. The method includes delivering an electric current through an object in contact with the first electrode and the second electrode; controlling, by the processor, the electric current delivered by the first electrode and the second electrode to have a specific waveform; and providing a notification at a predetermined time to notify a user to move the apparatus.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: April 6, 2021
    Assignee: ZIIP, INC.
    Inventors: David Mason, Melanie Simon, Ron Lisiecki
  • Patent number: 10959660
    Abstract: Systems and methods are provided for analyzing electrocardiogram (ECG) data of a patient using a substantial amount of ECG data. The systems receive ECG data from a sensing device positioned on a patient such as one or more ECG leads. The system may include an application that communicates with an ECG platform running on a server(s) that processes and analyzes the ECG data, e.g., using neural networks for delineation of the cardiac signal and classification of various abnormalities, conditions and/or descriptors. The processed ECG data is communicated from the server(s) for display in a user-friendly and interactive manner with enhanced accuracy.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: March 30, 2021
    Assignee: Cardiologs Technologies SAS
    Inventors: Jia Li, Romain Pomier, Chiara Scabellone, Cyril Gaudefroy, Benjamin Barre, Julien Fontanarava, Christophe Gardella, Mathieu Sornay, Thomas Bordier
  • Patent number: 10960206
    Abstract: Described is a low voltage, pulsed electrical stimulation device for controlling expression of, for example, follistatin, a muscle formation promotion protein, by tissues. Epicardial stimulation is especially useful for heart treatment. Follistatin controlled release is also useful for treating other ailments, such as erectile dysfunction, aortic aneurysm, and failing heart valves.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: March 30, 2021
    Assignee: LEONHARDT VENTURES LLC
    Inventors: Howard J. Leonhardt, Jorge Genovese